Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases
1Service des Maladies de l'Appareil Digestif, Hôpital Saint-Eloi, Montpellier, France.
Abstract:
Fifteen cases of hepatitis related to a combination of amoxycillin and clavulanic acid are reported. Most patients were aged 60 years or more and there were more men than women (sex ratio 4:1). The amoxycillin-clavulanic acid had been given at doses ranging from 0.5 to 6 g/day (mean 2 g/day) for seven to 60 days (mean 18 days). In 11 cases, the first symptoms appeared one to four weeks after stopping treatment. Jaundice was observed in all patients and was frequently associated with pruritus. Serum aminotransferase activities were increased in all patients and were generally two to 10 times the upper limit of normal. Serum alkaline phosphatase activity was considerably increased, from two to seven times the upper limit of normal. Histological examination of the liver, performed in seven patients, showed centri- or panlobular cholestasis in all cases, associated with granulomatous hepatitis in one. The prognosis of amoxycillin-clavulanic acid induced hepatitis seemed to be good. None of the patients exhibited biological or clinical features of hepatic failure and the course of the disease was characterised by the resolution of jaundice within one to eight weeks and a complete recovery within four to 16 weeks. Taking into account the number of treated subjects and reported cases, we estimated the risk of developing hepatitis with this drug combination to be very low, probably below 1/100,000. Our data suggest that the risk of hepatotoxicity may be increased in elderly men given lengthy treatment. The association of hepatitis and signs of hypersensitivity may suggest an immunoallergic mechanism of hepatotoxicity in some patients.
Insights
Hepatitis linked to amoxicillin-clavulanic acid is rare, affecting mostly older men. Symptoms appear weeks after treatment, but recovery is typical within months, suggesting a low overall risk.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Drug-Induced Liver Injury
Background:
- Amoxicillin-clavulanic acid is a widely used antibiotic combination.
- Drug-induced liver injury (DILI) is a significant concern in clinical practice.
- Hepatitis associated with antibiotic use requires careful monitoring and characterization.
Purpose of the Study:
- To report and characterize cases of hepatitis associated with amoxicillin-clavulanic acid.
- To investigate the clinical presentation, laboratory findings, and outcomes of this specific drug-induced hepatitis.
- To estimate the incidence and identify potential risk factors for amoxicillin-clavulanic acid-induced hepatitis.
Main Methods:
- Retrospective case series analysis of fifteen patients diagnosed with hepatitis.
- Review of clinical data, including patient demographics, treatment details, symptoms, laboratory results (liver enzymes), and liver histology.
- Estimation of the incidence of hepatitis based on reported cases and estimated drug usage.
Main Results:
- Fifteen cases of hepatitis were identified, predominantly in men over 60 years old.
- Hepatitis symptoms, including jaundice and pruritus, often appeared 1-4 weeks after treatment cessation.
- Elevated aminotransferases and alkaline phosphatase were consistent findings; liver histology showed cholestasis. Recovery was generally complete within 4-16 weeks.
- The estimated risk of hepatitis was very low (below 1/100,000), but potentially higher in elderly men with prolonged treatment.
Conclusions:
- Amoxicillin-clavulanic acid can cause hepatitis, characterized by cholestasis and a generally good prognosis.
- Elderly men receiving prolonged treatment may be at increased risk.
- The findings suggest a possible immunoallergic mechanism in some cases of drug-induced hepatitis.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Drug Toxicity: Allergic Reactions
Hepatitis
Cholecystitis


